Avidity Partners Management LP Cytokinetics Inc Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $10.6 Million - $17.9 Million	166,000 New	166,000 $11.6 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $5.63 Million - $7.71 Million	-168,700 Reduced 40.1%	252,000 $8.87 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $3.07 Million - $4.38 Million	85,700 Added 25.58%	420,700 $19.3 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $12.9 Million - $18.3 Million	335,000 New	335,000 $16.2 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.49B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.